Account

Table 1 The pharmacokinetic parameters of PAC and PAC-csMSN

From: RETRACTED ARTICLE: Effect of Paclitaxel-Mesoporous Silica Nanoparticles with a Core-Shell Structure on the Human Lung Cancer Cell Line A549

Formulation	Cmax (μg/ml)	Tmax (h)	t1/2 (h)	AUC (μg/ml*h)
PAC	44.76 ± 8.061	3.632 ± 0.875	4.271 ± 1.174	133.8 ± 21.45
PAC-csMSN	61.32 ± 13.82	4.316 ± 1.214	5.456 ± 2.057	358.4 ± 32.56

Back to article page